Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
125M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
46K
-
Shares change
-
+2.4K
-
Total reported value, excl. options
-
$107K
-
Value change
-
+$5.57K
-
Number of buys
-
1
-
Price
-
$2.32
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q4 2023
1 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46K shares
of 125M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (19.4M shares), VR Adviser, LLC (11.3M shares), BALYASNY ASSET MANAGEMENT L.P. (9.7M shares), Bain Capital Life Sciences Investors, LLC (8.66M shares), BlackRock Inc. (7.84M shares), SILVERARC CAPITAL MANAGEMENT, LLC (6.42M shares), VANGUARD GROUP INC (6.24M shares), Nextech Invest Ltd. (5.98M shares), MORGAN STANLEY (4.13M shares), and MILLENNIUM MANAGEMENT LLC (3.39M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.